Literature DB >> 9207398

Activated protein C resistance can be associated with recurrent fetal loss.

B Brenner1, H Mandel, N Lanir, J Younis, H Rothbart, G Ohel, Z Blumenfeld.   

Abstract

As thrombosis of placental vessels may result in recurrent fetal loss, we analysed 39 consecutive women with recurrent fetal loss of unknown cause for activated protein C resistance. Factor V Leiden (FVL) mutation (19 cases) or APC resistance without FVL (nine cases) were found among these 39 women. Evaluation of 128 pregnancies in 19 patients with factor V Leiden mutation and 56 gestations in nine women with acquired APC resistance, revealed over 50% first-trimester abortions and 17% late abortions. Intra-uterine fetal death occurred in nine out of 19 FVL patients (47%). Only 34 of 184 gestations (18%) in hereditary or acquired APC-resistance women resulted in a live birth, with 11 of the 34 (32%) being premature deliveries. These data suggest that, in some patients with recurrent fetal loss, hereditary and acquired APC resistance are potential causes of vascular placental insufficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207398     DOI: 10.1046/j.1365-2141.1997.882901.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  The relationship between activated protein C-resistance and recurrent abortion.

Authors:  W Dong; W Wei; M Lin
Journal:  J Tongji Med Univ       Date:  2000

Review 2.  Thrombophilia and its treatment in pregnancy.

Authors:  A Eldor
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

Review 3.  The effect of factor V Leiden carriage on maternal and fetal health.

Authors:  Dena Bloomenthal; Peter von Dadelszen; Robert Liston; Laura Magee; Peter Tsang
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

4.  The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility.

Authors:  Pierpaolo Di Micco; Maristella D'Uva; Ida Strina; Antonio Mollo; Valeria Amato; Alferio Niglio; Giuseppe De Placido
Journal:  J Transl Med       Date:  2004-11-09       Impact factor: 5.531

Review 5.  Thrombophilia and pregnancy.

Authors:  Michael J Kupferminc
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

6.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.